Health CanadaType II
Quetiapine 25 mg: The affected lot (quetiapine 25 mg) may contain sertraline 50 ...
Published: September 2, 2022Recall ID: 64532Category: generalCountry: Canada
Reason for Recall / Hazard
Health products
Product Description & Identification
Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.Contact the recalling firm if you have any questions about the recall.Report any health product related side effects to Health Canada.Report any other health product safety complaints to Health Canada.
Affected Products
Quetiapine 25 mg
Additional Source Details
| Field | Value |
|---|---|
| N I D | 64532 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/quetiapine-25-mg-affected-lot-quetiapine-25-mg-may-contain-sertraline-50-mg-tablets |
| Issue | Health products |
| Title | Quetiapine 25 mg: The affected lot (quetiapine 25 mg) may contain sertraline 50 mg tablets. |
| Product | Quetiapine 25 mg |
| Archived | 0 |
| Category | Drugs |
| Last updated | 2022-09-02 |
| Organization | Drugs and health products |
| Recall class | Type II |
| What you should do | Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.Contact the recalling firm if you have any questions about the recall.Report any health product related side effects to Health Canada.Report any other health product safety complaints to Health Canada. |